Tag Archives: cancer

Healthy lifestyle may help mitigate high genetic risk of cancer

Healthy lifestyle factors such as abstinence from smoking and drinking, low body mass index, and exercise correlated with decreased cancer incidence, even in individuals with a high genetic risk. As genetic research continues to uncover loci, or areas in DNA, with specific changes that influence cancer risk, researchers can define polygenic risk scores (PRS) —… Read More »

With ‘evolved’ treatment landscape, Merck pulls Keytruda’s FDA nod in third-line stomach cancer

Two months after a key FDA panel voted down Merck’s conditional nod for Keytruda as a third-line treatment for certain stomach cancer patients, the company says it’s pulling the plug on the indication.  Following consultation with the FDA, Merck on Thursday said it will voluntarily withdraw its U.S. accelerated approval for Keytruda as a third-line… Read More »

“Blood test finds 50 types of cancer” – we’ve been down this path before

Shoddy, incomplete, fawning news coverage of screening tests is one of the most clearly established problems in health news coverage – something HealthNewsReview.org has revealed countless times over the past 15 years. A public relations news release 22 days ago – from “a healthcare company whose mission is to detect cancer early” – touted study… Read More »

New Therapy for Aggressive Prostate Cancer Improves Survival

Advertisement Continue reading the main story Supported by Continue reading the main story New Therapy for Aggressive Prostate Cancer Improves Survival The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers. Prostate cancer is the second-leading cause of cancer death among American men, after… Read More »

FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell… Read More »